# ADR 512 — Enterprise Biotechnology Supply Chain Intelligence Platform (P217-M)

## Status

Accepted

## Context

P217-L established biomedical manufacturing intelligence. P217-M defines Biotechnology Supply Chain Intelligence: bio logistics, cold chain OS, biological inventory intelligence, material traceability, supply digital twins and autonomous logistics agents — before Bio Regulatory (P217-N).

## Decision

1. SoR remains `biotechnology` / `CAP-PLT-BIO-001` for bio supply *intelligence* — never inventory/pharmacy/EMR/LIMS SoR.
2. Fabric: `meos_bio_supply_chain_intelligence_fabric`.
3. API: `/api/v1/biotechnology/bio-supply-chain*`.
4. Six supply-chain layers; Bio Logistics OS, Cold Chain OS, inventory categories and AI engines.
5. All inference via P214-Z ACL only — `no_module_local_llm`.
6. Cold chain integrity and human logistics oversight mandatory; never untraceable biological material movement.
7. Twins via P217-G; manufacturing via P217-L; product via P217-K; robotics via P216-Z; quantum via P215-Z.
8. Never replace Core, AI, Quantum, Robotics, hospital EMR, LIMS, pharmacy, inventory, prior P217 fabrics including Bio Manufacturing.
9. Foundation for P217-N.

## Consequences

Positive: governed bio logistics layer for regulatory and sustainability phases.  
Negative: cold-chain deviation / emergency logistics catalogs must stay aligned as autonomous distribution deepens.

## Alternatives rejected

- Sibling `bio_supply_chain` BC owning inventory or pharmacy SoR.
- Module-local LLM or moving biological materials without traceability.
- Merging generic inventory SoR into biotechnology.

## Related

Law: `ENTERPRISE_BIOTECHNOLOGY_BIO_SUPPLY_CHAIN.md` · Prior: ADR 499–511 · Next: P217-N
